|
||||||
|
||||||
FMF-GermanyWelcome to
|
||
 |
||
 |
|
|
|
|
|
|
|
 |
Goals and Responsibilities |
|
|
|
Information Material |
|
|
|
Press Review |
|
|
|
Contact |
|
|
|
Imprint |
|
Privacy policy |
|
|
|
|
|
|
|
|
 |
|
|||
 |
 |
Deutsch | |
 |
|
English | |
|
|
|
 |
|
 |
|
 |
|
| The FMF-Germany is a registered charitable organisation composed of specially trained colleagues (prenatal diagnosticians), human geneticists and laboratory physicians. It aims at providing all interested pregnant women in their first third of pregnancy with a standardised tool for prenatal diagnosis which goes beyond the usual prenatal care measures and which is capable of meeting the highest possible quality requirements. |
|
|||||
| This non-invasive early screening method consists of a focused ultrasound examination of the fetus between the 11th and 14th week of pregnancy. It involves the measurement of so-called "nuchal translucency" and the collection of a maternal blood sample for detection of free beta-hCG and PAPP-A (pregnancy-associated plasma protein-A). A special computer programme then assesses the individual risk of chromosome abnormality. It enlightens not only about the possibility of a chromosomal disorder, but also informs about the risk of any other fetal anomaly. |
| The high quality of examination demanded by the FMF-Germany is ensured at all times because only those colleagues are approved as examiners who have successfully completed a theoretical and practical examination at an FMF-certified training centre and who will submit to regular quality control reviews in 12-month time intervals. The same applies to all laboratories certified by the FMF-Germany. Laboratories undertake to apply FMF-approved measurement procedures only, and to participate in international interlaboratory trials. | |
| All colleagues concerned with prenatal diagnosis are greatly welcomed to share in the voluntary quality concept of the FMF-Germany. | |
| Prof. Dr. E. Merz | |
| First President of the FMF-Germany |
